• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Traumatic Brain Injury (TBI) - Articles and news items


Vasopharm enrols first patient in phase III traumatic brain injury trial

Industry news / 8 September 2016 / Niamh Louise Marriott, Digital Content Producer

Vasopharm’s ronopternin (VAS203) will be evaluated for its safety and efficacy as the first patient is enrolled into the nostra phase III (NO Synthase in TRAumatic Brain Injury) trial – a clinical study to assess whether the drug can be used as a initial treatment for moderately to severely injured closed head traumatic brain (TBI) injury patients…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +